HEADER STRUCTURAL PROTEIN 03-JUN-09 3HOP TITLE STRUCTURE OF THE ACTIN-BINDING DOMAIN OF HUMAN FILAMIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: FILAMIN-A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ACTIN-BINDING DOMAIN; COMPND 5 SYNONYM: ALPHA-FILAMIN, FILAMIN-1, ENDOTHELIAL ACTIN-BINDING PROTEIN, COMPND 6 ACTIN-BINDING PROTEIN 280, ABP-280, NON-MUSCLE FILAMIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLNA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX HTB KEYWDS CALPONIN HOMOLOGY DOMAIN, ACTIN BINDING DOMAIN, ACETYLATION, ACTIN- KEYWDS 2 BINDING, ALTERNATIVE SPLICING, CYTOPLASM, CYTOSKELETON, DISEASE KEYWDS 3 MUTATION, PHOSPHOPROTEIN, POLYMORPHISM, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.R.CLARK,G.M.SAWYER,S.P.ROBERTSON,A.J.SUTHERLAND-SMITH REVDAT 4 01-NOV-23 3HOP 1 REMARK SEQADV REVDAT 3 01-NOV-17 3HOP 1 REMARK REVDAT 2 01-DEC-09 3HOP 1 JRNL REVDAT 1 13-OCT-09 3HOP 0 JRNL AUTH A.R.CLARK,G.M.SAWYER,S.P.ROBERTSON,A.J.SUTHERLAND-SMITH JRNL TITL SKELETAL DYSPLASIAS DUE TO FILAMIN A MUTATIONS RESULT FROM A JRNL TITL 2 GAIN-OF-FUNCTION MECHANISM DISTINCT FROM ALLELIC JRNL TITL 3 NEUROLOGICAL DISORDERS JRNL REF HUM.MOL.GENET. V. 18 4791 2009 JRNL REFN ISSN 0964-6906 JRNL PMID 19773341 JRNL DOI 10.1093/HMG/DDP442 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 28211 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.252 REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1466 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2034 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.35 REMARK 3 BIN R VALUE (WORKING SET) : 0.3540 REMARK 3 BIN FREE R VALUE SET COUNT : 91 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3602 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 139 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.19000 REMARK 3 B22 (A**2) : 4.66000 REMARK 3 B33 (A**2) : -1.47000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.315 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.247 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.917 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.886 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3718 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5071 ; 1.651 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 462 ; 6.653 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 163 ;39.178 ;25.031 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 651 ;16.312 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;17.571 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 575 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2784 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2306 ; 2.051 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3733 ; 3.101 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1412 ; 2.225 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1332 ; 2.979 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS; PHENIX.REFINE WAS MAINLY USED TO REFINE THIS REMARK 3 STRUCTURE, HOWEVER THE LAST PROGRAM USED WAS REFMAC REMARK 4 REMARK 4 3HOP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1000053393. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28211 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 44.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1WKU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 0.2M LITHIUM SULFATE, REMARK 280 0.1M TRIS HCL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.92500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.14000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.61000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.14000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.92500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.61000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 ALA A -1 REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 HIS A 5 REMARK 465 SER A 6 REMARK 465 ARG A 7 REMARK 465 ALA A 8 REMARK 465 GLY A 9 REMARK 465 GLN A 10 REMARK 465 SER A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 GLY A 14 REMARK 465 ALA A 15 REMARK 465 ALA A 16 REMARK 465 PRO A 17 REMARK 465 GLY A 18 REMARK 465 GLY A 19 REMARK 465 GLY A 20 REMARK 465 VAL A 21 REMARK 465 ASP A 22 REMARK 465 THR A 23 REMARK 465 ARG A 24 REMARK 465 ASP A 25 REMARK 465 ALA A 26 REMARK 465 GLU A 27 REMARK 465 MET A 28 REMARK 465 PRO A 29 REMARK 465 ALA A 30 REMARK 465 THR A 31 REMARK 465 GLU A 32 REMARK 465 LYS A 33 REMARK 465 ASP A 34 REMARK 465 LEU A 35 REMARK 465 ALA A 36 REMARK 465 ASP A 156 REMARK 465 GLU A 157 REMARK 465 GLU A 158 REMARK 465 GLU A 159 REMARK 465 ASP A 160 REMARK 465 GLU A 161 REMARK 465 GLU A 162 REMARK 465 GLY B -2 REMARK 465 ALA B -1 REMARK 465 MET B 0 REMARK 465 ALA B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 HIS B 5 REMARK 465 SER B 6 REMARK 465 ARG B 7 REMARK 465 ALA B 8 REMARK 465 GLY B 9 REMARK 465 GLN B 10 REMARK 465 SER B 11 REMARK 465 ALA B 12 REMARK 465 ALA B 13 REMARK 465 GLY B 14 REMARK 465 ALA B 15 REMARK 465 ALA B 16 REMARK 465 PRO B 17 REMARK 465 GLY B 18 REMARK 465 GLY B 19 REMARK 465 GLY B 20 REMARK 465 VAL B 21 REMARK 465 ASP B 22 REMARK 465 THR B 23 REMARK 465 ARG B 24 REMARK 465 ASP B 25 REMARK 465 ALA B 26 REMARK 465 GLU B 27 REMARK 465 MET B 28 REMARK 465 PRO B 29 REMARK 465 ALA B 30 REMARK 465 THR B 31 REMARK 465 GLU B 32 REMARK 465 LYS B 33 REMARK 465 ASP B 34 REMARK 465 LEU B 35 REMARK 465 ALA B 36 REMARK 465 GLU B 37 REMARK 465 ASP B 38 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 37 CG CD OE1 OE2 REMARK 470 ASP A 38 CG OD1 OD2 REMARK 470 ARG A 96 CD NE CZ NH1 NH2 REMARK 470 LYS A 120 CD CE NZ REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 TRP A 155 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 155 CZ3 CH2 REMARK 470 LYS A 164 CG CD CE NZ REMARK 470 LYS A 165 CG CD CE NZ REMARK 470 ARG A 171 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 268 CD CE NZ REMARK 470 LYS B 43 CD CE NZ REMARK 470 LYS B 120 CG CD CE NZ REMARK 470 GLU B 158 CG CD OE1 OE2 REMARK 470 GLU B 159 CG CD OE1 OE2 REMARK 470 ASP B 160 CG OD1 OD2 REMARK 470 GLU B 161 CG CD OE1 OE2 REMARK 470 GLU B 162 CG CD OE1 OE2 REMARK 470 LYS B 164 CG CD CE NZ REMARK 470 LYS B 165 CG CD CE NZ REMARK 470 ARG B 190 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 220 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 226 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 189 -83.49 -151.16 REMARK 500 LYS A 268 56.17 23.89 REMARK 500 ASP B 160 43.32 -108.69 REMARK 500 PRO B 184 99.34 -69.68 REMARK 500 SER B 189 -97.95 -136.01 REMARK 500 LYS B 220 63.08 -119.53 REMARK 500 VAL B 252 151.47 -47.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 270 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 270 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HOC RELATED DB: PDB REMARK 900 DISEASE ASSOCIATED POINT MUTANT MUTANT E254K REMARK 900 RELATED ID: 3HOR RELATED DB: PDB REMARK 900 LOWER RESOLUTION STRUCTURE, CRYSTALLISED IN THE PRESENCE OF 5MM DTT DBREF 3HOP A 2 269 UNP P21333 FLNA_HUMAN 2 269 DBREF 3HOP B 2 269 UNP P21333 FLNA_HUMAN 2 269 SEQADV 3HOP GLY A -2 UNP P21333 EXPRESSION TAG SEQADV 3HOP ALA A -1 UNP P21333 EXPRESSION TAG SEQADV 3HOP MET A 0 UNP P21333 EXPRESSION TAG SEQADV 3HOP ALA A 1 UNP P21333 EXPRESSION TAG SEQADV 3HOP GLY B -2 UNP P21333 EXPRESSION TAG SEQADV 3HOP ALA B -1 UNP P21333 EXPRESSION TAG SEQADV 3HOP MET B 0 UNP P21333 EXPRESSION TAG SEQADV 3HOP ALA B 1 UNP P21333 EXPRESSION TAG SEQRES 1 A 272 GLY ALA MET ALA SER SER SER HIS SER ARG ALA GLY GLN SEQRES 2 A 272 SER ALA ALA GLY ALA ALA PRO GLY GLY GLY VAL ASP THR SEQRES 3 A 272 ARG ASP ALA GLU MET PRO ALA THR GLU LYS ASP LEU ALA SEQRES 4 A 272 GLU ASP ALA PRO TRP LYS LYS ILE GLN GLN ASN THR PHE SEQRES 5 A 272 THR ARG TRP CYS ASN GLU HIS LEU LYS CYS VAL SER LYS SEQRES 6 A 272 ARG ILE ALA ASN LEU GLN THR ASP LEU SER ASP GLY LEU SEQRES 7 A 272 ARG LEU ILE ALA LEU LEU GLU VAL LEU SER GLN LYS LYS SEQRES 8 A 272 MET HIS ARG LYS HIS ASN GLN ARG PRO THR PHE ARG GLN SEQRES 9 A 272 MET GLN LEU GLU ASN VAL SER VAL ALA LEU GLU PHE LEU SEQRES 10 A 272 ASP ARG GLU SER ILE LYS LEU VAL SER ILE ASP SER LYS SEQRES 11 A 272 ALA ILE VAL ASP GLY ASN LEU LYS LEU ILE LEU GLY LEU SEQRES 12 A 272 ILE TRP THR LEU ILE LEU HIS TYR SER ILE SER MET PRO SEQRES 13 A 272 MET TRP ASP GLU GLU GLU ASP GLU GLU ALA LYS LYS GLN SEQRES 14 A 272 THR PRO LYS GLN ARG LEU LEU GLY TRP ILE GLN ASN LYS SEQRES 15 A 272 LEU PRO GLN LEU PRO ILE THR ASN PHE SER ARG ASP TRP SEQRES 16 A 272 GLN SER GLY ARG ALA LEU GLY ALA LEU VAL ASP SER CYS SEQRES 17 A 272 ALA PRO GLY LEU CYS PRO ASP TRP ASP SER TRP ASP ALA SEQRES 18 A 272 SER LYS PRO VAL THR ASN ALA ARG GLU ALA MET GLN GLN SEQRES 19 A 272 ALA ASP ASP TRP LEU GLY ILE PRO GLN VAL ILE THR PRO SEQRES 20 A 272 GLU GLU ILE VAL ASP PRO ASN VAL ASP GLU HIS SER VAL SEQRES 21 A 272 MET THR TYR LEU SER GLN PHE PRO LYS ALA LYS LEU SEQRES 1 B 272 GLY ALA MET ALA SER SER SER HIS SER ARG ALA GLY GLN SEQRES 2 B 272 SER ALA ALA GLY ALA ALA PRO GLY GLY GLY VAL ASP THR SEQRES 3 B 272 ARG ASP ALA GLU MET PRO ALA THR GLU LYS ASP LEU ALA SEQRES 4 B 272 GLU ASP ALA PRO TRP LYS LYS ILE GLN GLN ASN THR PHE SEQRES 5 B 272 THR ARG TRP CYS ASN GLU HIS LEU LYS CYS VAL SER LYS SEQRES 6 B 272 ARG ILE ALA ASN LEU GLN THR ASP LEU SER ASP GLY LEU SEQRES 7 B 272 ARG LEU ILE ALA LEU LEU GLU VAL LEU SER GLN LYS LYS SEQRES 8 B 272 MET HIS ARG LYS HIS ASN GLN ARG PRO THR PHE ARG GLN SEQRES 9 B 272 MET GLN LEU GLU ASN VAL SER VAL ALA LEU GLU PHE LEU SEQRES 10 B 272 ASP ARG GLU SER ILE LYS LEU VAL SER ILE ASP SER LYS SEQRES 11 B 272 ALA ILE VAL ASP GLY ASN LEU LYS LEU ILE LEU GLY LEU SEQRES 12 B 272 ILE TRP THR LEU ILE LEU HIS TYR SER ILE SER MET PRO SEQRES 13 B 272 MET TRP ASP GLU GLU GLU ASP GLU GLU ALA LYS LYS GLN SEQRES 14 B 272 THR PRO LYS GLN ARG LEU LEU GLY TRP ILE GLN ASN LYS SEQRES 15 B 272 LEU PRO GLN LEU PRO ILE THR ASN PHE SER ARG ASP TRP SEQRES 16 B 272 GLN SER GLY ARG ALA LEU GLY ALA LEU VAL ASP SER CYS SEQRES 17 B 272 ALA PRO GLY LEU CYS PRO ASP TRP ASP SER TRP ASP ALA SEQRES 18 B 272 SER LYS PRO VAL THR ASN ALA ARG GLU ALA MET GLN GLN SEQRES 19 B 272 ALA ASP ASP TRP LEU GLY ILE PRO GLN VAL ILE THR PRO SEQRES 20 B 272 GLU GLU ILE VAL ASP PRO ASN VAL ASP GLU HIS SER VAL SEQRES 21 B 272 MET THR TYR LEU SER GLN PHE PRO LYS ALA LYS LEU HET PO4 A 270 5 HET PO4 B 270 5 HETNAM PO4 PHOSPHATE ION FORMUL 3 PO4 2(O4 P 3-) FORMUL 5 HOH *139(H2 O) HELIX 1 1 ALA A 39 LYS A 42 5 4 HELIX 2 2 LYS A 43 LYS A 58 1 16 HELIX 3 3 CYS A 59 SER A 61 5 3 HELIX 4 4 GLY A 74 GLN A 86 1 13 HELIX 5 5 PHE A 99 GLU A 117 1 19 HELIX 6 6 ASP A 125 ASP A 131 1 7 HELIX 7 7 ASN A 133 SER A 149 1 17 HELIX 8 8 THR A 167 LEU A 180 1 14 HELIX 9 9 SER A 189 GLN A 193 5 5 HELIX 10 10 GLY A 195 ALA A 206 1 12 HELIX 11 11 ASP A 212 TRP A 216 5 5 HELIX 12 12 LYS A 220 GLY A 237 1 18 HELIX 13 13 THR A 243 VAL A 248 1 6 HELIX 14 14 ASP A 253 SER A 262 1 10 HELIX 15 15 SER A 262 ALA A 267 1 6 HELIX 16 16 ALA B 39 LYS B 42 5 4 HELIX 17 17 LYS B 43 LYS B 58 1 16 HELIX 18 18 GLY B 74 GLN B 86 1 13 HELIX 19 19 PHE B 99 GLU B 117 1 19 HELIX 20 20 ASP B 125 ASP B 131 1 7 HELIX 21 21 ASN B 133 SER B 149 1 17 HELIX 22 22 SER B 151 TRP B 155 5 5 HELIX 23 23 THR B 167 LEU B 180 1 14 HELIX 24 24 SER B 189 GLN B 193 5 5 HELIX 25 25 GLY B 195 ALA B 206 1 12 HELIX 26 26 ASP B 212 TRP B 216 5 5 HELIX 27 27 LYS B 220 GLY B 237 1 18 HELIX 28 28 THR B 243 VAL B 248 1 6 HELIX 29 29 ASP B 253 SER B 262 1 10 HELIX 30 30 SER B 262 ALA B 267 1 6 SSBOND 1 CYS A 59 CYS B 59 1555 1555 2.02 SITE 1 AC1 4 LYS A 220 PRO A 221 VAL A 222 THR A 223 SITE 1 AC2 4 LYS B 220 PRO B 221 VAL B 222 THR B 223 CRYST1 57.850 71.220 158.280 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017286 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014041 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006318 0.00000